0.7894
13-مارس-25 14:51:49
15 متأخرة بدقائق
الأسهم
-0.0356
-4.32%
نطاق اليوم
0.7600 - 0.8247
ISIN
N/A
المصدر
NASDAQ
Xilio Therapeutics Announces Preclinical Data Demonstrating Anti-Tumor Activity and Tolerability of XTX301, a Tumor-Selective IL-12, at Society for Immunotherapy in Cancer Annual Meeting
12 نوفمبر 2021 06:00:03 بحسب Nasdaq GlobeNewswire
Xilio Therapeutics Announces Closing of Initial Public Offering
26 أكتوبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire